N11102014

    About  Us       R & D        Pipeline          Partnership           Investor Center         News & Events          Careers

Investor Center Partership News & Events2013 Pipeline Research & Development About Us
Press Releases
More Ascletis News
Copyright © 2011 Ascletis Inc. All rights reserved.
Careers News & Events2013
 Home            Contact  

ascletis

   Home

Nov 10, 2014 /  Ascletis gains exclusive China market rights from Presidio to  clinical stage hepatitis C virus (HCV) NS5A inhibitor PPI-668  >>

N11102014

Apr 30, 2013 /  Ascletis gains China market rights from Janssen to a clinical stage HIV protease inhibitor  >>

N04302013

May 09, 2014 /  Ascletis presents at the 3rd ACHA  Conference in Beijing >>

N05092014

Jun 09, 2014 /  Ascletis featured in the interview of Dr. Darren Ji, vice president of Roche by Medicine Economic News  >>

N06092014 浙ICP备11050387号

Oct 28, 2014 /  Ascletis to build commercial cGMP facility in Shaoxing Binhai New City  >>

N10282014

中文

   Home-Ch Contact    Home

Think Outside the Box

Research & Development
Partnership
Pipeline
Research & Development Partership

Ascletis is a specialty therapeutics company dedicated to discovering

and developing important new treatments for cancer and infectious diseases.

Pipeline
HIV in China

Status and Treatment Trends of HCV

HCV IN CHINA

HCV

Danoprevir